Hypokinetic dysarthria also manifests as a lack of variability in pitch or loudness, wherein a patient may demonstrate monopitch, monoloudness, or reduced use of conversational inflection.

Cite this: Nonpharmacological Management of Hypokinetic Dysarthria in ParkinsonÂ’s Disease - Medscape - Jan 01, 2006. Abstract and Introduction Nonpharmacological Treatment ...

OBJECTIVES The pathophysiology of dysarthria can preferentially be studied in patients with the rare lacunar stroke syndrome of “isolated dysarthria”. METHODS A single study was carried out on seven ...

Following initial improvement on colchicine and corticosteroids, he deteriorated with respiratory symptoms, dysarthria and knee pain. Investigations revealed abscesses in brain and soft tissue with ...

In this paper, we present our recent improvements within the CapisciAMe project, an Italian initiative aimed at investigating the usage of deep learning strategies for automatic speech recognition in ...

Tirzepatide (Mounjaro, Zepbound) may have neuroprotective mechanisms against Alzheimer's disease and dementia, a review suggested. (Metabolic Brain Disease) An instantaneous brain-to-voice ...

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

UC Davis engineers developed a brain-to-voice neuroprosthesis that enables fluent, real-time speech for paralyzed individuals.

The Wisconsin Department of Health Services (DHS) has reported that as of June 2025, there are three reported cases of ...

Also, little range of motion was observed in articulation. In evaluating combined basis involving breathing, phonation, articulation, and resonance, the patient showed slowness of speech, the ...

Aphasia in MND may be masked by dysarthria and missed if not specifically examined. METHODS —A battery of neuropsychological and language tests was administered to patients presenting consecutively ...